Search results
AbbVie (NYSE:ABBV) Stock Rating Reaffirmed by Cantor Fitzgerald
ETF DAILY NEWS· 11 hours agoAbbVie (NYSE:ABBV – Get Free Report)‘s stock had its “overweight” rating reissued by Cantor Fitzgerald in a note issued to investors on Thursday, Benzinga ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Alaska Permanent Fund Corp
ETF DAILY NEWS· 24 hours agoThe institutional investor owned 70,497 shares of the company’s stock after selling 1,297 shares during the period. Alaska Permanent Fund Corp’s holdings in AbbVie ...
Pensionfund Sabic Sells 3,100 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 2 days agoThe institutional investor owned 16,600 shares of the company’s stock after selling 3,100 shares during the quarter. AbbVie comprises approximately 0.9% ...
CCM Investment Advisers LLC Trims Stock Holdings in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 days ago:ABBV – Free Report) by 0.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 93,921 shares of the company’s stock< ...
AbbVie (NYSE:ABBV) Stock Price Up 1.5% on Analyst Upgrade
ETF DAILY NEWS· 4 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shares rose 1.5% during trading on Tuesday after Piper Sandler raised their price target on the stock from $185.00 ...
Safeguard Financial LLC Takes $235,000 Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 22 hours agoSafeguard Financial LLC acquired a new stake in AbbVie Inc. (NYSE:ABBV – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with ...
Modus Advisors LLC Acquires 450 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 3 days agoModus Advisors LLC raised its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 2.0% in the 1st quarter, according to the company in its most recent Form 13F ...
B. Riley Wealth Advisors Inc. Sells 15,193 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 4 days agoB. Riley Wealth Advisors Inc. trimmed its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 10.4% during the fourth quarter, Holdings Channel.com reports. The ...
AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider
Zacks· 4 days agoFree Report) ending at $171.36, denoting a +0.99% adjustment from its last day's close. This change outpaced the S&P 500's 0.25% gain on the day. In that same time, the Medical sector gained ...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 3 days agoAbbVie has also submitted an application in the EU, seeking approval for Skyrizi for the UC...